Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years old~* Initiated dialysis in past 3 months~* Signed informed consent~* Attending University of Iowa dialysis unit for duration of the study~Exclusion Criteria:~* Age \>70~* Unable to provide consent~* Currently taking fish oil supplementation~* rhythm other than sinus~* implantable cardioverter-defibrillator~* pacemaker~* myocardial infarction,revascularization or unstable angina in past 3 months~* other hospitalization in past 3 months~* symptomatic heart failure~* known left ventricular ejection fraction \< 30%~* history of a significant bleeding disorder~* severe bleeding episode requiring hospitalization in past 3 months (GI bleed or hemorrhagic stroke)~* unexplained HgB drop \> 2 gm/dl in past 3 months~* chronic warfarin or anti-coagulation therapy (such as Lovenox)~* pregnant or nursing mothers~* allergic to fish, fish oil or fish products~* Participation in other trials of investigational products~* other characteristics as determined by the investigator that would make sudy participation inappropriate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 4 capsules inert oil Placebo each day for 16 weeks
- Omega-3 Fatty Acid Ethyl Esters (Type: ACTIVE_COMPARATOR): 4 capsules Omega-3 Fatty Acid Esters each day for 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).